Find Reports

Select Report Type

Learn More about Reports

Reimbursement Review

Displaying 1251 - 1258 of 1258

Health Technology Review

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 576 - 589 of 589

Horizon Scan

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 101 - 111 of 111

Projects in Progress

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 26 - 40 of 40

View All Reports

Filter

Project Sub Line

Last Updated

Min

Max

Items per page

Export to CSV

Displaying 1476 - 1500 of 2093

Please scroll or swipe to the right to view the full content.

Title	Files	Last Updated Sort ascending	Project Line	Project Sub Line	Status	Project Number
Tolvaptan	SR0435 Jinarc.pdf SR0435_complete_Jinarc-Feb_26_16_e.pdf SR0435_Jinarc_CL_Report.pdf SR0435_Jinarc_PE_Report.pdf SR0435 Jinarc Template_PI_Submissions.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0435-000
Peginterferon beta-1a	SR0440 Plegridy.pdf SR0440_complete_Plegridy-Dec-21-15_e.pdf SR0440_Plegridy_CL_Report.pdf SR0440_Plegridy_PE_Report.pdf SR0440_Plegridy Patient Input Submission.pdf	Sep 7, 2018	Reimbursement Review		Complete	SR0440-000
ixekizumab	SR0558_Taltz_PsA_Aug_23_18.pdf SR0558_TaltzPsA_CL_Report.pdf SR0558_TaltzPsA_PE_Report.pdf SR0558_TaltzPsA_PI_Submissions.pdf	Aug 31, 2018	Reimbursement Review		Complete	SR0558-000
abobotulinumtoxinA	SR0556_Dysport_Therapeutic_Aug_23_18.pdf SR0556_Dysport_Therapeutic_CL_Report.pdf SR0556_Dysport_Therapeutic_PE_Report.pdf SR0556_Dysport_PI_Submissions.pdf	Aug 31, 2018	Reimbursement Review		Complete	SR0556-000
nitisinone	SR0554_Nitisinone_Aug_23_18.pdf SR0554_Nitisinone_CL_Report.pdf SR0554_Nitisinone_PE_Report.pdf SR0554_Nitisinone_PI_Submissions.pdf	Aug 31, 2018	Reimbursement Review		Complete	SR0554-000
Alecensaro for Non-Small Cell Lung Cancer (first line) – Details	pcodr_provfund_alectinib_alecensaro_nsclc_1ln.pdf pcodr_alectinib_alecensaro_nsclc_1stln_fn_rec.pdf pcodr_alectinib_alecensaro_nsclc_1stln_fn_cgr.pdf pcodr_alectinib_alecensaro_nsclc_1stln_fn_egr.pdf pcodr_alectinib_alecensaro_nsclc_1stln_in_rec.pdf pcodr_alectinib_alecensaro_nsclc_1stln_pagfdk.pdf pcodr_alectinib_alecensaro_nsclc_1stln_fdk_hlr.pdf pcodr_alectinib_alecensaro_nsclc_1stln_clnfdk.pdf pcodr_alectinib_alecensaro_nsclc_1stln_coi_pt.pdf pcodr_alectinib_alecensaro_nsclc_1stln_coi_cln.pdf	Aug 13, 2018	Reimbursement Review		Complete	PC0125-000
CADTH Pharmaceutical Reviews Update — Issue 1		Aug 9, 2018	Reimbursement Review	Pharmaceutical Review Update
Darunavir/cobicistat/emtricitabine/tenofovir alafenamide	SR0552_cdr_complete_Symtuza_July_27_18.pdf SR0552_Symtuza_Combined_Report.pdf SR0552_Symtuza_PI_Submissions.pdf	Aug 8, 2018	Reimbursement Review		Complete	SR0552-000
Lonsurf for Metastatic Colorectal Cancer – Details	pcodr_provfund_trifluridine_tipiracil_lonsurf_mcrc.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_fn_rec.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_fn_cgr.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_fn_egr.pdf pcodr_trifluridine-tipiracil_Lonsurf_mCRC_in_rec.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_pagfdk.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_fdk_taiho.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_ptfdk.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_clnfdk.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_coi_pt.pdf pcodr_trifluridine_tipiracil_lonsurf_mcrc_coi_cln.pdf	Jul 23, 2018	Reimbursement Review		Complete	PC0122-000
Besponsa for Acute Lymphoblastic Leukemia – Details	pcodr_provfund_inotuzumab-ozogamicin_besponsa_all.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_fn_rec.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_fn_cgr.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_fn_egr.pdf pcodr_inotuzumab_besponsa_ALL_in_rec.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_pagfdk.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_fdk_pfizer.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_clnfdk.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_coi_pt.pdf pcodr_inotuzumab_ozogamicin_besponsa_all_coi_cln.pdf	Jul 23, 2018	Reimbursement Review		Complete	PC0121-000
brodalumab	TS0001-PsO-Updated-Streamlined-Rec.pdf SR0547_cdr_complete_Siliq_June_22_18.pdf SR0547_Siliq_CL_Report.pdf SR0547_Siliq_PE_Report.pdf SR0547_Brodalumab_PI_Submissions.pdf	Jul 16, 2018	Reimbursement Review		Complete	SR0547-000
dupilumab	SR0533_cdr_complete_Dupixent_July_9_2018.pdf SR0533_Dupixent_CL_Report.pdf SR0533_Dupixent_PE_Report.pdf SR0533_Duxipent_Patient_Submsissions.pdf	Jul 10, 2018	Reimbursement Review		Complete	SR0533-000
letermovir	SR0545_cdr_complete_Prevymis_June_22_2018.pdf SR0545_Prevymis_CL_Report.pdf SR0545_Prevymis_PE_Report.pdf SR0545_Prevymis_PI_Submissions.pdf	Jul 9, 2018	Reimbursement Review		Complete	SR0545-000
Tecentriq for Non-Small Cell Lung Cancer – Details	pcodr_profund_10115_atezolizumab_tecentriq_nsclc.pdf pcodr_atezolizumab_tecentriq_nsclc_fn_rec.pdf pcodr_atezolizumab_tecentriq_nsclc_fn_cgr.pdf pcodr_atezolizumab_tecentriq_nsclc_fn_egr.pdf pcodr_atezolizumab_tecentriq_nsclc_in_rec.pdf pcodr_atezolizumab_tecentriq_nsclc_pagfdk.pdf pcodr_atezolizumab_tecentriq_nsclc_fdk_hlroche.pdf pcodr_atezolizumab_tecentriq_nsclc_clnfdk.pdf pcodr_atezolizumab_tecentriq_nsclc_coi_pt.pdf pcodr_atezolizumab_tecentriq_nsclc_coi_cln.pdf	Jul 6, 2018	Reimbursement Review		Complete	PC0115-000
Drugs for Rare Diseases: A Review of National and International Health Technology Assessment Agencies and Public Payers’ Decision-Making Processes		Jun 26, 2018	Health Technology Review	Environmental Scan	Completed	ES0326-000
netupitant / palonosetron	SR0548_cdr_complete_Akynzeo_June_22_18.pdf SR0548_Akynzeo_CL_Report.pdf SR0548_Akynzeo_PE_Report.pdf	Jun 22, 2018	Reimbursement Review		Complete	SR0548-000
Dolutegravir / rilpivirine	SR0551_cdr_complete_Juluca_June_22_18.pdf SR0551_Juluca_CL_Report.pdf SR0551_Juluca_PE_Report.pdf SR0551_Juluca_PI_Submissions.pdf	Jun 22, 2018	Reimbursement Review		Complete	SR0551-000
Recommendations Framework for Drugs for Rare Diseases: A Review of National and International Health Technology Assessment Agencies and Public Payers’ Decision-Making Processes		Jun 22, 2018	Health Technology Review			ES0326-000
ledipasvir, sofosbuvir	SF0465 Harvoni.pdf SF0465_complete_Harvoni RFA_May_19-16.pdf SF0465_Harvoni_Hep_C_RfA_PI_Submissions.pdf SF0465_Harvoni_RfA_Review_Report.pdf	May 23, 2018	Reimbursement Review		Complete	SF0465-000
Tiotropium bromide	SR0412 Spiriva Respimat.pdf SR0412-complete-Spiriva-Respimat-July-20-15-e.pdf SR0412_SpirivaRespimat_CL_Report.pdf SR0412_SpirivaRespimat_PE_Report.pdf SR0412_SpirivaRespimat_PI_Submissions.pdf	May 23, 2018	Reimbursement Review		Complete	SR0412-000
Opdivo for classical Hodgkin Lymphoma (after failure of ASCT) – Details	pcodr_profund_nivolumab_opdivo_chl_fail_asct.pdf pcodr_nivolumab_opdivo_cHL_fn_rec.pdf pcodr_nivolumab_opdivo_cHL_fn_egr.pdf pcodr_nivolumab_opdivo_cHL_fn_cgr.pdf pcodr_nivolumab_opdivo_chl_in_rec.pdf pcodr_nivolumab_opdivo_cHL_pagfdk.pdf pcodr_nivolumab_opdivo_cHL_ptfdk.pdf pcodr_nivolumab_opdivo_cHL_clnfdk.pdf pcodr_nivolumab_opdivo_cHL_fdk_bms.pdf pcodr_nivolumab_opdivo_cHL_coi_pt.pdf pcodr_nivolumab_opdivo_cHL_coi_cln.pdf	May 22, 2018	Reimbursement Review		Complete	PC0120-000
latanoprost	SR0541_cdr_complete_Monoprost_apr-26-18_e.pdf SR0541_Monoprost_CL_Report.pdf SR0541_Monoprost_PE_Report.pdf	May 17, 2018	Reimbursement Review		Complete	SR0541-000
ocrelizumab	SR0542_cdr_complete_Ocrevus_PPMS_Apr_30_18_e.pdf SR0542_Ocrevus_PPMS_CL_Report.pdf SR0542_Ocrevus_PPMS_PE_Report.pdf SR0542_Ocrevus_PPMS_PI_Submissions.pdf	May 10, 2018	Reimbursement Review		Complete	SR0542-000
Stivarga for Unresectable Hepatocellular Carcinoma (HCC) – Details	pcodr_provfund_10119_regorafenib_stivarga_unresectable_hcc.pdf pcodr_regorafenib_stivarga_hcc_fn_rec.pdf pcodr_regorafenib_stivarga_hcc_fn_cgr.pdf pcodr_regorafenib_stivarga_hcc_fn_egr.pdf pcodr_regorafenib_stivarga_hcc_in_rec.pdf pcodr_regorafenib_stivarga_hcc_pagfdk.pdf pcodr_regorafenib_stivarga_hcc_fdk_bayer.pdf pcodr_regorafenib_stivarga_hcc_ptfdk.pdf pcodr_regorafenib_stivarga_hcc_clnfdk.pdf pcodr_regorafenib_stivarga_hcc_coi_pt.pdf pcodr_regorafenib_stivarga_hcc_coi_cln.pdf	May 3, 2018	Reimbursement Review		Complete	PC0119-000
Kisqali for Metastatic Breast Cancer – Details	pcodr_provfund_10112_ribocliclib_kisqali_mbc.pdf pcodr_ribociclib_kisqali_mbc_fn_rec.pdf pcodr_ribociclib_kisqali_mbc_fn_cgr.pdf pcodr_ribociclib_kisqali_mbc_fn_egr.pdf pcodr_ribociclib_kisqali_mbc_in_rec.pdf pcodr_ribociclib_kisqali_mbc_pagfdk.pdf pcodr_ribociclib_kisqali_mbc_fdk_novartis.pdf pcodr_ribociclib_kisqali_mbc_ptfdk.pdf pcodr_ribociclib_kisqali_mbc_clnfdk.pdf pcodr_ribociclib_kisqali_mbc_coi_pt.pdf pcodr_ribociclib_kisqali_mbc_coi_cln.pdf	May 3, 2018	Reimbursement Review		Complete	PC0112-000